Targeting epigenetic regulators in acute myeloid leukemia

Research in Progress Seminar
May 20, 2025
at 4:30 PM
Hörsaal Pavillon

Dr. Hannah Uckelmann
“Targeting epigenetic regulators in acute myeloid leukemia”

Dr. Hannah Uckelmann is Max-Eder junior research group leader at University Hospital Goethe Universität Frankfurt, Germany. Her lab focuses on studying the epigenetic regulation of self-renewal programs during cancer development and the discovery of new therapeutics. During her postdoctoral fellowship at Dana-Farber Cancer Institute Dr. Uckelmann discovered an unexpected role of mutant NPM1 on chromatin representing the molecular basis for the effectiveness Menin-MLL inhibitors which are currently in clinical trials. She was recently awarded an ERC starting grant to investigate the epigenetic mechanisms driving leukemogenesis.

We are looking foward to your attendance!

Keyword: haematology, targeted therapy